SCHEMBL18985227

SCHEMBL18985227

COC(=O)c1c(F)cc(Br)c(N)c1C

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.41
TSHR P16473 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
CISD2 Q8N5K1 2/20 0.37
CYP3A4 P08684 2/20 0.37
ACHE P22303 1/20 0.37
GRM6 O15303 1/20 0.36
GRM5 P41594 1/20 0.36
NOTUM Q6P988 1/20 0.36
SOS1 Q07889 1/20 0.35
PRKCZ Q05513 1/20 0.35
HPGD P15428 2/20 0.35
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 1/20 0.35
ATM Q13315 1/20 0.35
HDAC1 Q13547 2/20 0.35
HDAC6 Q9UBN7 2/20 0.35
POLB P06746 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30867539 1.00 LMNA (0.41) LMNATSHRNPSR1CISD2CYP3A4
SCHEMBL25104302 0.87 LMNA (0.41) LMNATSHRNPSR1CISD2CYP3A4
SCHEMBL8116715 0.85 CYP3A4 (0.40) LMNATSHRCISD2CYP3A4ACHE
SCHEMBL30798376 0.83 SOS1 (0.40) LMNATSHRNPSR1CYP3A4ACHE
SCHEMBL24718692 0.83 SOS1 (0.40) LMNATSHRNPSR1CYP3A4ACHE
SCHEMBL18786779 0.83 CYP3A4 (0.46) CISD2CYP3A4ACHEGRM6GRM5
SCHEMBL24649335 0.82 SOS1 (0.39) LMNATSHRNPSR1CYP3A4ACHE
SCHEMBL30427242 0.82 SOS1 (0.39) LMNATSHRNPSR1CYP3A4ACHE
SCHEMBL31024678 0.82 LMNA (0.42) LMNATSHRNPSR1CYP3A4ACHE
SCHEMBL31426608 0.81 CA1 (0.37) CYP3A4ACHEKDM4EHDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4583867-A2 SODIUM CHANNEL BLOCKING COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE Latigo Biotherapeutics, Inc. (US) 2025-07-16 EP disclosed
CN-119894509-A Sodium channel blocking compounds, derivatives thereof, and methods of use thereof 拉堤果生物医疗股份有限公司 2025-04-25 CN disclosed
WO-2024054622-A2 SODIUM CHANNEL BLOCKING COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE LATIGO BIOTHERAPEUTICS, INC. (US) 2024-03-14 WO disclosed
US-10779540-B2 Benzamide compounds and their use as herbicides BASF SE (DE) 2020-09-22 US disclosed
EP-3390372-B1 BENZAMIDE COMPOUNDS AND THEIR USE AS HERBICIDES BASF SE (DE) 2020-06-03 EP disclosed
EP-3390372-B1 BENZAMIDE COMPOUNDS AND THEIR USE AS HERBICIDES BASF SE (DE) 2020-06-03 EP disclosed
US-20180360046-A1 Benzamide Compounds and Their Use as Herbicides BASF SE (DE) 2018-12-20 US disclosed
EP-3390372-A1 BENZAMIDE COMPOUNDS AND THEIR USE AS HERBICIDES BASF SE (DE) 2018-10-24 EP disclosed
WO-2017102275-A1 BENZAMIDE COMPOUNDS AND THEIR USE AS HERBICIDES BASF SE (DE) 2017-06-22 WO disclosed
WO-2017102275-A1 BENZAMIDE COMPOUNDS AND THEIR USE AS HERBICIDES BASF SE (DE) 2017-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10779540-B2 Benzamide compounds and their use as herbicides DDT, DNPH1, BBOX1 LMNA 3595/4885TSHR 2289/4885NPSR1 2240/4885
US-20180360046-A1 Benzamide Compounds and Their Use as Herbicides DDT, DNPH1, BBOX1 LMNA 3595/4885TSHR 2289/4885NPSR1 2240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.